Researchers in Japan have developed a promising laboratory technique that could help overcome a major challenge in regenerative medicine: producing fully mature heart muscle cells from human stem cells.

The method involves doubling the number of chromosome sets in induced pluripotent stem cells (iPS cells) before transforming them into cardiomyocytes, the specialized cells responsible for the heart’s contractions. The resulting cells displayed stronger and faster contractions than heart cells produced using conventional methods.

A New Approach to Heart Cell Development

Human iPS cells can be generated from ordinary body cells and reprogrammed to develop into different cell types. Scientists have been exploring their potential for repairing damaged tissues and developing new treatments for serious diseases.

However, heart muscle cells created from conventional iPS cells often retain characteristics associated with early development. Their functional immaturity has presented a significant obstacle to applications such as heart tissue repair and transplantation.

To address this limitation, the Japanese research team focused on a natural biological process called polyploidization, in which a cell acquires additional sets of chromosomes as it matures.

Most human cells carry 46 chromosomes arranged in 23 pairs. Tetraploid cells contain four sets of chromosomes rather than the usual two sets.

The researchers established iPS cells with doubled chromosome sets and subsequently guided them to develop into heart muscle cells.

Laboratory Tests Reveal Stronger Contractions

The team compared heart muscle cells derived from the chromosome-doubled stem cells with those produced through conventional methods.

The experimental results showed several differences. The newly developed cells were larger, displayed changes in gene activity associated with greater maturity, and contained more mitochondria, the structures responsible for generating cellular energy.

Researchers also found improvements in mitochondrial function, an important characteristic for heart muscle cells that must continuously generate energy to sustain contractions.

Electrical impedance measurements provided additional evidence of functional differences. The heart cells developed from tetraploid iPS cells produced stronger contractions and reached their contraction peaks more rapidly than the comparison cells.

Together, these observations suggest that increasing the chromosome sets of stem cells before differentiation may help produce heart muscle cells with characteristics closer to those of mature cells in the human body.

Potential Applications in Medical Research

The technique could have several important applications if further research establishes its safety and effectiveness.

One potential area is regenerative medicine, where scientists are investigating ways to repair heart damage and develop cell-based treatments for heart failure. More mature laboratory-grown heart cells could also improve the testing of experimental medicines and help researchers create more representative models of cardiac diseases.

The approach may have relevance beyond cardiology. Certain other cell types, including liver cells and some skeletal muscle-related cells, also undergo changes in chromosome number during maturation. Researchers may investigate whether similar strategies can improve the development of these cells for laboratory studies and future medical applications.

More Research Is Needed Before Clinical Use

Despite the encouraging laboratory findings, the technique should not be interpreted as an established treatment for heart disease.

Further studies will be necessary to determine how reliably the cells can be produced, whether they maintain their improved characteristics over time, and whether they can function safely when incorporated into living heart tissue.

Scientists will also need to assess potential risks associated with chromosome alterations, including abnormal cell behaviour and unintended effects after transplantation.

The findings represent a step forward in efforts to improve stem cell-derived heart muscle cells. If the method can be validated in further research, it could support the development of better disease models, more informative drug-testing systems and future regenerative medicine approaches.